The COVID19-101 project in partnership with the Institut Pasteur aimed to characterize the immune response induced by the SARS-CoV-2 vaccine candidate as part of a phase I clinical study.
This work resulted in a publication in eBioMedicine.
New publication about COVID-19 vaccine on eBioMedicine
